Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study
Warner K. Huh, William E. Brady, Paula M. Fracasso, Don S. Dizon, Matthew A. Powell, Bradley J. Monk, Charles A. Leath, Lisa M. Landrum, Edward J. Tanner, Erin K. Crane, Stefanie Ueda, Michael McHale, Carol Aghajanian
Topics & Concepts
MedicineGynecologic oncologyInternal medicineCervical cancerProgression-free survivalOncologyBevacizumabPopulationAdverse effectPhases of clinical researchStage (stratigraphy)ChemotherapyCancerBiologyPaleontologyEnvironmental healthImmunotherapy and Immune ResponsesEndometrial and Cervical Cancer TreatmentsCervical Cancer and HPV Research